Download video

Phase III VOLGA: durvalumab + tremelimumab + enfortumab vedotin for neoadjuvant MIBC

33 views

VJOncology

1 month ago

Phase III VOLGA: durvalumab + tremelimumab + enfortumab vedotin for neoadjuvant MIBC

Phase III VOLGA: durvalumab + tremelimumab + enfortumab vedotin for neoadjuvant MIBC

Phase III VOLGA: durvalumab + tremelimumab + enfortumab vedotin for neoadjuvant MIBC
0:33
Phase III VOLGA: durvalumab + tremelimumab + enfortumab vedotin for neoadjuvant MIBC
by VJOncology
Bladder cancer highlights at ASCO 2022
0:39
Bladder cancer highlights at ASCO 2022
by VJOncology
ctDNA clearance linked to improved outcomes in MIBC neoadjuvant therapy: results from VOLGA study
1:12
ctDNA clearance linked to improved outcomes in MIBC neoadjuvant therapy: results from VOLGA study
by VJOncology
VOLGA: impact of ctDNA clearance on survival outcomes in bladder cancer
1:27
VOLGA: impact of ctDNA clearance on survival outcomes in bladder cancer
by VJOncology
NIAGARA trial# Muscle invasive Bladder cancer# MIBC # Durvalumab #Neoadjuvant
5:15
NIAGARA trial# Muscle invasive Bladder cancer# MIBC # Durvalumab #Neoadjuvant
by Cancer education made simple # Chandrakanth MV
CheckMate 274 \& EV-301: highlights in UC from ASCO GU
4:22
CheckMate 274 \& EV-301: highlights in UC from ASCO GU
by VJOncology
Neoadjuvant Immune Checkpoint Inhibition for Muscle Invasive Bladder Cancer
15:22
Neoadjuvant Immune Checkpoint Inhibition for Muscle Invasive Bladder Cancer
by Grand Rounds in Urology
Immunotherapy for Muscle Invasive Bladder Cancer
19:21
Immunotherapy for Muscle Invasive Bladder Cancer
by Grand Rounds in Urology
Neoadjuvant sacituzumab govitecan for muscle-invasive bladder cancer
0:40
Neoadjuvant sacituzumab govitecan for muscle-invasive bladder cancer
by VJOncology
Advances in Muscle Invasive Bladder Cancer- 2024 Bladder Cancer Video Library
2:18
Advances in Muscle Invasive Bladder Cancer- 2024 Bladder Cancer Video Library
by GRACE - Global Resource for Advancing Cancer Education
EV-201: enfortumab vedotin for bladder cancer
2:20
EV-201: enfortumab vedotin for bladder cancer
by VJOncology
Durvalumab as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
4:39
Durvalumab as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
by PracticeUpdate
Bladder: enfortumab vedotin + pembrolizumab \& VESPER trial
1:14
Bladder: enfortumab vedotin + pembrolizumab \& VESPER trial
by VJOncology
State of the Art - Neoadjuvant chemotherapy becoming standard of care in MIBC?
17:58
State of the Art - Neoadjuvant chemotherapy becoming standard of care in MIBC?
by European Association of Urology
Future therapy options for muscle-invasive bladder cancer
2:00
Future therapy options for muscle-invasive bladder cancer
by VJOncology
VESPER: dd-MVAC as perioperative chemotherapy for MIBC
7:38
VESPER: dd-MVAC as perioperative chemotherapy for MIBC
by VJOncology
Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC
5:13
Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC
by ecancer
Phase III trial on neoadjuvant intravesical mitomycin C (MMC) treatment for bladder cancer
3:37
Phase III trial on neoadjuvant intravesical mitomycin C (MMC) treatment for bladder cancer
by VJOncology
Overcoming challenges in localized bladder cancer management via biomarkers
1:25
Overcoming challenges in localized bladder cancer management via biomarkers
by VJOncology
Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Bladder Cancer
5:25
Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Bladder Cancer
by Grand Rounds in Urology